CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Creo Medical Group PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Creo Medical Group PLC
Unit 2 Beaufort Park,, Beaufort Park Way
Phone: +44 1291606005p:+44 1291606005 CHEPSTOW, NP16 5UH  United Kingdom Ticker: CREOCREO
Business Summary
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Charles A.Spicer 53
Chief Executive Officer, Executive Director Craig J.Gulliford 1/1/2012 1/1/2012
Chief Financial Officer, Executive Director Richard J.Rees 7/1/2016 7/1/2016
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Creo Medical Ltd. Creo House Unit 2 Chepstow United Kingdom
Creo Medical Ltd. 9 Avenue Jean Prouve Saint-Die-Des-Vosges France
Creo Medical Ltd. 9 Avenue Jean Prouve Saint-Die-Des-Vosges France

Business Names
Business Name
Albyn Medical Ltd.
Albyn Medical SL
CREO
Creo Medical Ltd.
Creo Medical SL

General Information
Number of Employees: 279 (As of 6/30/2023)
Outstanding Shares: 361,251,418 (As of 7/27/2023)
Stock Exchange: LON


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024